Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 5 from your keywords: subject="Antiplat"
cover
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect…
Comment Share
Gurbel PA

The antiplatelet effects of the Platelet Inhibition and Patient Outcomes (PLATO) trial dose of ticagrelor in patients nonresponsive to clopidogrel and after they switch agents are unknown

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication :…
Comment Share
Dawson DL

Cilostazol is a new phosphodiesterase inhibitor that suppresses platelet aggregation and also acts as a direct arterial vasodilator. This prospective, randomized, placebo-controlled, parallel-group clinical trial evaluated the efficacy of cilostazol for treatment of stable, moderately severe intermittent claudication

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Coronary Stent Restenosis in Patients Treated With Cilostazol
Comment Share
Douglas JS

Restenosis after implantation of coronary artery stents remains a significant clinical problem. We undertook a randomized, double-blind, placebo-controlled trial to determine whether cilostazol, a drug that suppresses intimal proliferation, would reduce renarrowing in patients after stent implantation in native coronary arteries

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Extended dual antiplatelet therapy for Asian patients with acute coronary syn…
Comment Share
Chen WWC, et al

Recommendations were produced for the following nine risk factors: old age (>65), chronic kidney disease (CKD), diabetes mellitus (DM), recurrent myocardial infarction (MI), multi-vessel disease (MVD), multiple stents, bioresorbable vascular scaffold (BVS) stent, left main stenting and peripheral artery disease (PAD). Strong ischaemic risk factors include DM, recurrent MI, MVD and/or >3 stents;…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therap…
Comment Share
Levine GN

Incorporation of new study results, medications, or devices that merit modification of existing clinical practice guideline recommendations, or the addition of new recommendations, is critical to ensuring that guidelines reflect current knowledge, available treatment options, and optimum medical care. To keep pace with evolving evidence, the American College of Cardiology (ACC)/ American Heart…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-